These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1203541)

  • 1. Hypercoagulability and hypofibrinolysis in sickle-cell disease.
    Stathakis NE; Papayannis AG; Papayatos H; Scliros P; Gardikas C
    Blut; 1975 Dec; 31(6):355-60. PubMed ID: 1203541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation fibrinolysis in sickle-cell disease.
    Gordon PA; Breeze GR; Mann JR; Stuart J
    J Clin Pathol; 1974 Jun; 27(6):485-9. PubMed ID: 4412492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technics for the study of the blood coagulation and fibrinolytic system].
    Lasch HG; Heene D
    Internist (Berl); 1968 Feb; 9(2):42-8. PubMed ID: 4234941
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica.
    Leslie J; Langler D; Serjeant GR; Serjeant BE; Desai P; Gordon YB
    Br J Haematol; 1975 Jun; 30(2):159-66. PubMed ID: 1201207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired fibrinolysis in sickle cell disease. Relation to crisis and infection.
    Green D; Kwaan HC RUIZ G
    Thromb Diath Haemorrh; 1970 Oct; 24(1):10-6. PubMed ID: 4249854
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of blood coagulatiion during haemoperfusion (author's transl)].
    Niessner H; Pichler M
    Wien Klin Wochenschr; 1977 May; 89(10):347-50. PubMed ID: 68628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state.
    Bayazit AK; Kilinç Y
    Pediatr Int; 2001 Dec; 43(6):592-6. PubMed ID: 11737735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on coagulation and fibrinolysis in blood from puerperal women with and without oestrogen treatment.
    Gjonnaess H; Fagerhol MK; Stormorken H
    Br J Obstet Gynaecol; 1975 Feb; 82(2):151-7. PubMed ID: 123756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of coagulation system in pathophysiology of sickle cell disease.
    Rickles FR; O'Leary DS
    Arch Intern Med; 1974 Apr; 133(4):635-41. PubMed ID: 4594398
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma fibrinolytic activity in sickle cell disease.
    Famodu AA
    Trop Geogr Med; 1988 Oct; 40(4):331-3. PubMed ID: 3227553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercoagulability in the nephrotic syndrome of children].
    Vargas R; Pizzuto J; Bosque JD; Santos D
    Arch Invest Med (Mex); 1975; 6(1):23-32. PubMed ID: 1156076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome.
    Onyemelukwe GC; Jibril HB
    Trop Geogr Med; 1992 Jan; 44(1-2):37-41. PubMed ID: 1496720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation and fibrinolytic mechanisms during and after normal childbirth.
    Bonnar J; McNicol GP; Douglas AS
    Br Med J; 1970 Apr; 2(5703):200-3. PubMed ID: 5443405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability in childhood cancer.
    Hathaway WE; Hays T
    J Pediatr Surg; 1975 Dec; 10(6):893-9. PubMed ID: 1202173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis in the dog.
    Cade JF; Robinson TF
    Can J Comp Med; 1975 Jul; 39(3):296-8. PubMed ID: 1139411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.
    Nsiri B; Gritli N; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
    Hematol Cell Ther; 1996 Jul; 38(3):279-84. PubMed ID: 8974793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation studies in the hyperacute and other forms of renal-allograft rejection.
    Colman RW; Braun WE; Busch GJ; Dammin GJ; Merrill JP
    N Engl J Med; 1969 Sep; 281(13):685-91. PubMed ID: 4898061
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls.
    Hagger D; Wolff S; Owen J; Samson D
    Blood Coagul Fibrinolysis; 1995 Apr; 6(2):93-9. PubMed ID: 7605884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation changes in hyperacute rejection of renal xenografts.
    Broersma RJ; Bullemer GD; Rosenberg JC; Lenaghan R; Rosenberg BF; Mammen EF
    Thromb Diath Haemorrh Suppl; 1969; 36():333-40. PubMed ID: 4393136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.